Source: Eur Respir Monogr 2017; 75: 159-184
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Sebastian R. Ott. Antifungals in pulmonary infections: to whom, when and how?. Eur Respir Monogr 2017; 75: 159-184

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary rehabilitation for bronchiectasis: if not now, when? Source: Eur Respir J, 53 (1) 1802474; 10.1183/13993003.02474-2018 Year: 2019 Thrombo-embolic pulmonary hypertension: which treatment should we choose? / Hypertension pulmonaire thrombo-embolique: quel traitement choisir ? Source: International Congress 2018 – French Programme 2018: Part II Year: 2018 Antibiotics for pulmonary infections: an overview Source: Eur Respir Monogr 2017; 75: 1-20 Year: 2017 Cured pulmonary tuberculosis population: what is next? Source: Virtual Congress 2020 – Pulmonary function and rehabilitation in non-respiratory disease Year: 2020 Pulmonary infections in HIV-infected patients: an update in the 21st century Source: Eur Respir J 2012; 39: 730-745 Year: 2012 Image-based recommendations for the evaluation of pulmonary embolism and arterial hypertension: what? when? how? Source: Virtual Congress 2020 – Image-based guidelines and recommendations in respiratory diseases Year: 2020 Diagnosis and treatment of pulmonary hypertension in COPD patients: how far should we go? Source: International Congress 2019 – Lung vessels in COPD: it is time to take them seriously! Year: 2019 Patients with recurrent tuberculosis in Istanbul: reactivation?, reinfection? Source: International Congress 2018 – Diagnosis of tuberculosis Year: 2018 Pneumonectomy in pulmonary tuberculosis. To do or not to do? Source: Annual Congress 2012 - Tuberculosis: invasive diagnostic and therapeutic interventions Year: 2012 Bronchial inflammation, respiratory symptoms and lung function in patients who finished treatment for pulmonary tuberculosis: is it the beginning of a new disease? Source: International Congress 2019 – Clinical aspects of airway diseases Year: 2019 How important is work as a risk for lung infections? A story of tuberculosis and pneumonia Source: Virtual Congress 2020 – How much lung disease is really caused by work, and how to assess the worker who wishes to continue working? Year: 2020 Treatment of pulmonary hypertension due to COPD: can we really hope in better? Source: Eur Respir J 2005; 26: Suppl. 49, 562s Year: 2005 Pulmonary infection with nocardia species in chronic respiratory patients: a report of 12 cases Source: Eur Respir J 2006; 28: Suppl. 50, 560s Year: 2006 Pulmonary aspergillosis: a clinical review Source: Eur Respir Rev 2011; 20: 156-174 Year: 2011 IPC-related pleural infection vs. colonisation - to treat or not to treat? Source: International Congress 2019 – Pleural infection and complicated pneumonia Year: 2019 Pulmonary infections: what to do when it's a bug that you do not know Source: Eur Respir J 2003; 21: 201 Year: 2003 Pulmonary hypertension: what can we learn from studies? Source: International Congress 2015 – Practising personalised medicine: why, when, and how? Year: 2015